[go: up one dir, main page]

ES8604578A1 - Procedimiento para preparar derivados de 1,4-dihidropiridina - Google Patents

Procedimiento para preparar derivados de 1,4-dihidropiridina

Info

Publication number
ES8604578A1
ES8604578A1 ES538157A ES538157A ES8604578A1 ES 8604578 A1 ES8604578 A1 ES 8604578A1 ES 538157 A ES538157 A ES 538157A ES 538157 A ES538157 A ES 538157A ES 8604578 A1 ES8604578 A1 ES 8604578A1
Authority
ES
Spain
Prior art keywords
dihydropyridine derivatives
procedure
preparing
substituent
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES538157A
Other languages
English (en)
Other versions
ES538157A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8604578A1 publication Critical patent/ES8604578A1/es
Publication of ES538157A0 publication Critical patent/ES538157A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE 1,4-DIHIDROPIRIDINA. CONSISTENTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (IA) CON UN AGENTE ALQUILANTE, PREFERENTEMENTE UN HALOGENURO DE ALQUILO, EN PRESENCIA DE HIDROXIDO DE SODIO, A TEMPERATURAS ENTRE 20 Y 40JC, Y EN EL CASO DE UN GRUPO ALQUILO SUSTITUIDO EN EL QUE EL SUSTITUYENTE PUEDE REACCIONAR CON EL HALOGENURO, SE PROTEGE EL SUSTITUYENTE Y, UNA VEZ FINALIZA LA ALQUILACION SE ELIMINA EL GRUPO PROTECTOR, OBTENIENDO DERIVADOS DE 1,4-DIHIDROPIRIDINA DE FORMULA (I). SIENDO: R1, METILO Y R2, ISOPROPILO, N-BUTILO, ISO-BUTILO Y OTROS, O VICEVERSA; Y R3, H O ALQUILO DE 1 A 6 C. SE UTILIZAN POR SUS PROPIEDADES FARMACEUTICAS.
ES538157A 1982-06-15 1984-11-30 Procedimiento para preparar derivados de 1,4-dihidropiridina Expired ES8604578A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH369382 1982-06-15
CH369282 1982-06-15

Publications (2)

Publication Number Publication Date
ES8604578A1 true ES8604578A1 (es) 1986-02-01
ES538157A0 ES538157A0 (es) 1986-02-01

Family

ID=25693638

Family Applications (2)

Application Number Title Priority Date Filing Date
ES523243A Expired ES8504179A1 (es) 1982-06-15 1983-06-14 "procedimiento para preparar derivados de 1,4-dihidropiridina".
ES538157A Expired ES8604578A1 (es) 1982-06-15 1984-11-30 Procedimiento para preparar derivados de 1,4-dihidropiridina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES523243A Expired ES8504179A1 (es) 1982-06-15 1983-06-14 "procedimiento para preparar derivados de 1,4-dihidropiridina".

Country Status (19)

Country Link
AU (1) AU1575383A (es)
BE (1) BE897000A (es)
CA (1) CA1208639A (es)
CH (1) CH660593A5 (es)
DE (1) DE3320616A1 (es)
DK (1) DK271183A (es)
ES (2) ES8504179A1 (es)
FI (1) FI832072L (es)
FR (1) FR2528431B1 (es)
GB (1) GB2122192B (es)
HU (1) HU191853B (es)
IT (1) IT1178353B (es)
NL (1) NL8302067A (es)
NZ (1) NZ204536A (es)
PH (1) PH23436A (es)
PT (1) PT76870B (es)
SE (1) SE8303385L (es)
WO (1) WO1984000033A1 (es)
ZA (1) ZA834409B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
AU1570588A (en) * 1987-03-27 1988-11-02 Byk Gulden Lomberg Chemische Fabrik Gmbh New intermediate products and process
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
CN100425599C (zh) * 2005-12-31 2008-10-15 清华大学 一种有机电致发光材料及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner

Also Published As

Publication number Publication date
GB8316054D0 (en) 1983-07-20
HU191853B (en) 1987-04-28
PH23436A (en) 1989-08-07
ES523243A0 (es) 1985-04-01
WO1984000033A1 (fr) 1984-01-05
AU1575383A (en) 1983-12-22
FR2528431B1 (fr) 1986-01-10
FI832072A7 (fi) 1983-12-16
PT76870B (en) 1986-02-27
FI832072L (fi) 1983-12-16
SE8303385D0 (sv) 1983-06-14
ZA834409B (en) 1985-02-27
SE8303385L (sv) 1983-12-16
IT1178353B (it) 1987-09-09
BE897000A (fr) 1983-12-09
CA1208639A (en) 1986-07-29
ES8504179A1 (es) 1985-04-01
FR2528431A1 (fr) 1983-12-16
NL8302067A (nl) 1984-01-02
GB2122192B (en) 1985-12-18
GB2122192A (en) 1984-01-11
DE3320616A1 (de) 1983-12-15
DK271183D0 (da) 1983-06-13
FI832072A0 (fi) 1983-06-08
PT76870A (en) 1983-07-01
ES538157A0 (es) 1986-02-01
CH660593A5 (de) 1987-05-15
DK271183A (da) 1983-12-16
NZ204536A (en) 1986-09-10
IT8348488A0 (it) 1983-06-13

Similar Documents

Publication Publication Date Title
SE8302693L (sv) Heterocykliska foreningar
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
DK162629C (da) 2-substituerede 1-aralkyl-imidazoler og farmaceutiske midler der indeholder disse, anvendelse heraf til fremstilling af farmaceutiske midler samt fremgangsmaade til fremstilling heraf
IT1171879B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica
ES8106486A1 (es) Un procedimiento para la preparacion de formulaciones de de-rivados de guanidina y 2-imidazolina.
ES8604578A1 (es) Procedimiento para preparar derivados de 1,4-dihidropiridina
SE8600913D0 (sv) Kemiska foreningar
PT89118A (pt) Processo para a preparacao de derivados de anilina e de composicoes farmaceuticas que os contem
FI840027A0 (fi) Disubstituerade prolinderivat, foerfaranden foer deras framstaellning och deras anvaendning
AR012603A1 (es) Inhibidor de proteasa, composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento; e intermediarios de sintesis
ES8707925A1 (es) Un procedimiento para la preparacion de derivados de aminofenol
IT1174756B (it) Composizioni antisolari contenenti almeno un composto di ammide viniloga e relativo impiego
JPS56103168A (en) Thiazole derivative, its preparation, and antihistaminic agent containing the same
ES8800898A1 (es) Un procedimiento para preparar derivados de azetidinona
DE3666038D1 (de) 1-aryl-4-nitropyrazoles
NO20003106D0 (no) Akronycin-forbindelser, fremstilling derav samt farmasøytiske sammensetninger omfattende slike
DK558786D0 (da) Basisk substituerede pyridinforbindelser, fremstilling deraf, samt laegemidler, indeholdende disse
ES374087A1 (es) Un procedimiento para la preparacion de agentes antibacte- rianos.
KR840006238A (ko) 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법
DK373985D0 (da) Substituerede pyridazinoner samt deres fremstilling og anvendelse
ES8201979A1 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
ES8504680A1 (es) Un procedimiento para la preparacion de derivados de benzamida
ES8406074A1 (es) Un procedimiento para la preparacion de benzacepinas.
BR0206206A (pt) Derivados de etoposide e análogos, e composições farmacêuticas contendo os mesmos
ES8500957A1 (es) Un procedimiento para preparar compuestos de cefalosporina.